Results 241 to 250 of about 458,490 (361)

Protective efficacy of a 'pan-fungal' vaccination strategy against experimental <i>Pneumocystis</i> infection in drug-immunosuppressed macaques. [PDF]

Front Immunol
Rabacal W, Hu A, Kirton G, Chapman TI, Wychrij D, Oworae KO, Norris KA.   +6 more
europepmc   +1 more source

The fate of meshed allograft skin in burned patients using cyclosporin immunosuppression

, 1989
James D. Frame, Roy Sanders, Tim Goodacre, Brian Morgan   +3 more
openalex   +1 more source

A Chirality‐Converted Bacteriolytic Dodecapeptide Regulates Vibrio‐Induced Polymicrobial Infection and Ameliorates Invasion‐Associated Gut Microbiota Disequilibrium

Advanced Science, EarlyView.
Multidrug‐resistant Vibrio infections are rising rapidly and threaten coastal populations worldwide. This study introduces D‐zp37, a chirality‐engineered antimicrobial peptide with exceptional potency against resistant Vibrio species. D‐zp37 kills planktonic cells, blocks mixed‐species biofilms, disrupts essential bacterial stress responses, and shows ...
Ping Zeng, Qipeng Cheng, Xiaoxu Zhang, Honglan Wang, Jinghan Zhang, Xinyi Ding, Pengfei Zhang, Lanhua Yi, Kwok‐Yin Wong, Kin‐Fai Chan, Sheng Chen, Sharon Shui Yee Leung   +11 more
wiley   +1 more source

The role of dendritic cells (DC) in Friend retrovirus-induced immunosuppression and immunotherapeutic applications of functionalized nanoparticles

, 2014
Limei Shen
openalex   +2 more sources

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Leveraging vascular normalization <i>via</i> eNOS activation to enhance the efficacy of PD-L1 blockade. [PDF]

Acta Pharm Sin B
Zhou Y, Gao H.
europepmc   +1 more source

The organ transplanted patient - immunological concepts and immunosuppression [PDF]

, 1991
Husberg, BS, Klintmalm, GBG, Starzl, TE
core  

Sa1811 – Genotype and Posst-Operative Immunosuppression Impact Surgical Recurrence in Crohn's Disease

, 2019
Mark Salem, Dalin Li, Mark E. Gerich, Shaohong Yang, Eric Vasiliauskas, Gaurav Syal, Christina Ha, Nirupama Bonthala, Shervin Rabizadeh, Karen Zaghiyan, Talin Haritunians, Gil Melmed, Stephan Targan, Phillip Fleshner, Dermot McGovern   +14 more
openalex   +1 more source

Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives

Advanced Science, EarlyView.
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård, Tatiana Bobrova, Amalie Leinebø, Thibault Leray, Shayamita Ghosh, Lorena García‐Hevia, Chiara Puccinelli, Lorenzo Riccio, Jacopo Sorani, Davide Bonifazi, Julien Caumartin, Emmanuel Donnadieu, Florence Gazeau, Roland Hischier, Else Marit Inderberg, Mónica L. Fanarraga, Maria Loustau, Bernd Nowack, Sébastien Wälchli, Cécilia Ménard‐Moyon   +19 more
wiley   +1 more source

Defining the Society of Pediatric Liver Transplantation (SPLIT) research agenda: A Delphi consensus project. [PDF]

Hepatol Commun
Wadhwani SI, Spector PR, Feldman AG, Furuya KN, Hartjes K, Jarasvaraparn C, Kelly B, Lerret SM, Mysore K, Pawaria A, Rosenthal P, Shui A, Slowik V, Taylor S, Vittorio J, Valentino PL, Society of Pediatric Liver Transplantation (SPLIT).   +16 more
europepmc   +1 more source